By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Natco Pharma Limited 

Natco House
Road No: 2, Banjara Hills
Hyderabad    500 033  India
Phone: 91-40-2354 7532 Fax: 91-40-2354 8243



Company News
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014 4:20:44 PM
Natco Pharma Limited, Orchid Chemicals Hit With A Strong Dose Of FDA Medicine 9/19/2014 6:08:33 AM
Bayer AG (BAY.F) Loses Nexavar Compulsory License Battle 9/18/2012 7:56:06 AM
Public Not to be Hit if Natco Pharma Limited Licence Cancelled: Bayer Corporation (BAY) 9/4/2012 7:20:48 AM
Natco Pharma Limited in Patent War With Bristol-Myers Squibb Company (BMY) 8/2/2012 7:43:08 AM
Pharma Industry Split Over Nod to Natco Pharma Limited to Sell Bayer AG (BAY.F)'s Cancer Drug; Verdict Opens Door for Cheaper Drugs 3/13/2012 7:46:24 AM
Teva Pharmaceutical Industries Limited (TEVA) Announces Court Adopts All Relevant Teva Claim Construction Interpretations in Copaxone® Patent Infringement Case Against Sandoz, Inc./Momenta Pharmaceuticals, Inc. (MNTA) and Mylan Pharmaceuticals, Inc. (MYL)/Natco Pharma Limited; Court Denies Mylan’s Summary Judgment Motion of Invalidity 8/29/2011 10:16:18 AM
Natco Pharma Limited Seeks 'Compulsory License' For Copy Of Pfizer Inc. (PFE) Drug 1/5/2011 6:54:38 AM
Watson Pharmaceuticals, Inc. (WPI) Confirms Development Agreement with Natco Pharma Limited for Generic Revlimid(R) 12/7/2010 10:48:04 AM
Celgene (CELG) Seeks To Stop Natco Pharma Limited's Generic Revlimid; Officially Notified of ANDA Filing Today 9/3/2010 7:18:31 AM